Roger Adsett
Operationeel Directeur bij INSMED INCORPORATED
Vermogen: 4 M $ op 30-04-2024
Actieve functies van Roger Adsett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INSMED INCORPORATED | Operationeel Directeur | 14-11-2019 | - |
Corporate Officer/Principal | 27-09-2016 | 14-11-2019 | |
LANDOS BIOPHARMA, INC. | Directeur/Bestuurslid | 08-03-2022 | - |
Independent Dir/Board Member | 08-03-2022 | - |
Loopbaan van Roger Adsett
Eerdere bekende functies van Roger Adsett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHIRE | Corporate Officer/Principal | 01-10-2005 | 01-09-2016 |
ASTRAZENECA PLC | Verkoop & Marketing | 01-11-1994 | 01-10-2005 |
Nexium, Inc. | Verkoop & Marketing | - | - |
AstraZeneca R & D Lund | Verkoop & Marketing | - | - |
Opleiding van Roger Adsett
Bucknell University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 6 |
Verenigd Koninkrijk | 2 |
Ierland | 2 |
Operationeel
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
INSMED INCORPORATED | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Nexium, Inc. | Finance |
AstraZeneca R & D Lund |
- Beurs
- Insiders
- Roger Adsett
- Ervaring